Leading the Way in Life Science Technologies

GEN Exclusives

More »

Assay Tutorials

More »
Jan 15, 2011 (Vol. 31, No. 2)

Bioanalysis of Oligonucleotide Therapeutics

LC-MS/MS Allows for Accurate and Sensitive HT Quantification

  • LC-MS/MS in Plasma

    To analyze TL0901 in complex biological matrices by LC-MS/MS, samples must be precleaned or extracted together with an appropriate internal standard (a 12-mer analog in this case) prior to running. We have found both solid-phase extraction and liquid-liquid extraction (LLE) methods were effective for the extraction of phosphorothiate oligonucleotides. However, LLE produced better and more consistent recovery (>75%).

    This method has been fully validated for quantitation of TL0901 in human plasma under good laboratory practice (GLP) conditions, including intra- and inter-day precision and accuracy, selectivity/specificity, metabolite interference, and various stability tests. The validated linear range is from 10.0 to 2,500 ng/mL; both inter-day and intra-day precisions were less than 6%, with a mean accuracy (%bias) of -10% to 1.0%. The assay matrix selectivity was also tested at lower level of quantification in 10 different lots of plasmas, and all stability tests are acceptable per the GLP guideline set forth by FDA.

    LC-MS/MS provides an unambiguous, sensitive, and efficient means of detecting and quantifying oligonucleotides in complex biological fluids. We have validated many LC-MS/MS assays for various structured oligonucleotides in various matrices and analyzed thousands of samples in support of both clinical and nonclinical GLP studies around the world. We believe that LC-MS/MS represents the future high-throughput platform for the bioanalysis of oligonucleotide therapeutics.

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »